Rapid Diagnosis of HT-1: Why Early Testing Changes Outcomes

Early diagnosis of Hereditary Tyrosinemia Type 1 helps protect the liver and kidneys. See which tests confirm HT-1 and what families should do next.

Oct 26, 2026 - 18:35
Oct 26, 2026 - 18:35
 0  1
Rapid Diagnosis of HT-1: Why Early Testing Changes Outcomes

Quick Answer

Hereditary Tyrosinemia Type 1 (HT-1) is diagnosed by detecting succinylacetone in blood or urine, often through newborn screening. The sooner it is found, the sooner treatment can begin, which lowers the risk of serious liver and kidney complications.

Why Speed Matters in HT-1

HT-1 is caused by a shortage of an enzyme called fumarylacetoacetate hydrolase (FAH). Without it, harmful substances build up and can damage the liver and kidneys, sometimes within the first months of life.

Treatment with NTBC (nitisinone) and a controlled diet works best when started early. Many families describe the days between a screening alert and treatment as the most stressful part of the journey, which is exactly why a fast, clear path matters.

How HT-1 Is Diagnosed

  1. Newborn screening. A few drops of blood from a heel prick are tested shortly after birth. Many programs look for succinylacetone because it is the most specific marker for HT-1.
  2. Confirmatory testing. If screening is positive, doctors repeat testing on blood and urine, including succinylacetone and amino acid levels.
  3. Liver and kidney assessment. Blood tests check liver function and clotting. Other markers, such as alpha-fetoprotein, may also be reviewed.
  4. Genetic testing. Analysis of the FAH gene can confirm the diagnosis and help with family planning.

Why not just test tyrosine?

High tyrosine can occur in many situations, including in healthy newborns and with other liver problems. Succinylacetone is more specific to HT-1, which is why screening programs that rely on tyrosine alone may miss cases or raise false alarms.

Symptoms That Should Prompt a Doctor Visit

If a baby was not screened, or screening was incomplete, watch for:

  • Poor feeding or poor weight gain
  • Repeated vomiting or irritability
  • Yellow skin or eyes
  • Swollen belly
  • Easy bruising or bleeding

These signs are not specific to HT-1, but they should never be ignored. Ask for urgent medical review.

What To Do After a Positive Screen

  • Call the clinic the same day. Ask for a referral to a metabolic specialist.
  • Do not wait for symptoms. A positive screen needs follow-up even if your baby looks well.
  • Write down questions. Ask about next tests, treatment timing and feeding advice.
  • Find support. Talk to other families through N.O.T.A. so you do not feel alone.

Screening Differs Around the World

Not every country screens for HT-1, and some screen differently. If you are expecting, or planning to move, ask your hospital or health ministry exactly which conditions are on the newborn panel. See our guide on treatment across the globe for more.

FAQs

Can HT-1 be diagnosed before symptoms appear? Yes. Newborn screening can identify HT-1 before symptoms start.

Is high tyrosine alone enough for a diagnosis? No. Succinylacetone and confirmatory tests are needed.

How fast should treatment begin after diagnosis? As soon as your specialist advises. Early treatment gives the best outcomes.

Is HT-1 inherited? Yes. It is an autosomal recessive condition, so both parents carry a changed gene copy.

Conclusion

Rapid diagnosis of HT-1 is one of the most powerful ways to protect a child's health. If you have a screening result you do not understand, or want to talk to families who have been through it, reach out to N.O.T.A. We are here to help you find the next step.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
notacares NOTA Cares is a global nonprofit organization dedicated to supporting individuals and families affected by tyrosinemia. It provides resources, education, and a strong support network while raising awareness about the condition. The organization connects communities worldwide, ensuring no patient goes untreated and every family receives guidance and support.